Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06959277 · ClinicalTrials.gov registry record · NA

Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems

A NA study of Peripheral Neuropathy Due to Chemotherapy and Peripheral Neuropathies, sponsored by RxFunction.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
6
Study locations

NCT06959277 is a NA study of Peripheral Neuropathy Due to Chemotherapy and Peripheral Neuropathies that is actively recruiting participants, run by RxFunction. The registered enrollment target is 200 participants, above the 28-participant average among 6 other Peripheral Neuropathy Due to Chemotherapy trials with a reported enrollment target (614% higher). The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06959277, a NA study of Peripheral Neuropathy Due to Chemotherapy and Peripheral Neuropathies, is actively recruiting participants, sponsored by RxFunction.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
6
Study locations

Study Summary

The goal of this clinical trial is to is to test whether Walkasins can help people with peripheral neuropathy maintain their balance better. The main question it aims to answer is whether participants who use Walkasins on an everyday basis over a six-month period will report better awareness of their foot placement on the ground. Researchers will compare Walkasins users to a control group of participants who are not using Walkasins to see if the device improves the users' performance on some standing and walking tests. Control group participants will get Walkasins after six months of being in the study. During the study participants will be asked to do the following: * Answer questions about their medical history and balance. * Do some standing and walking tests. Some of the tests will be timed. * Attend study visits and participate in study phone calls. * Keep track of any falls and notify study staff if they fall. * Wear the Walkasins device on a regular basis.

Conditions Studied

Peripheral Neuropathy Due to Chemotherapy Peripheral Neuropathies Peripheral Neuropathy With Type 2 Diabetes Balance Control in Elderly Gait Disorders

Interventions

  • DEVICE Walkasins
  • OTHER Fall Prevention Training

Study Locations (6)

Arizona

  • OrthoArizona--Mesa Arbor Avenue - Mesa

Massachusetts

  • Marcus Institute for Aging Research, Hebrew SeniorLife - Boston

Minnesota

  • Fairview Frontiers - Saint Paul

New York

  • Dent Neurologic Institute - Amherst

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Texas

  • University of Texas Medical Branch - Galveston

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2025-06-17
Est. Completion 2027-12-31
Phase NA

Sponsor

RxFunction

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06959277

The ClinicalTrials.gov registry entry for NCT06959277 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 28-participant average among 6 other Peripheral Neuropathy Due to Chemotherapy trials with a reported enrollment target (614% higher). The listed sponsor is RxFunction, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Peripheral Neuropathy Due to Chemotherapy appearing as the primary indexed condition, and to 2 interventions - of which Walkasins is the first listed.

NCT06959277 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Arizona, Massachusetts, Minnesota.

Frequently Asked Questions

What is clinical trial NCT06959277 about?

NCT06959277 is a clinical study titled "Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems". The goal of this clinical trial is to is to test whether Walkasins can help people with peripheral neuropathy maintain their balance better. The main question it aims to answer is whether participants who use Walkasins on an everyday basis over a six-month period will report better awareness of thei...

What is the current status of trial NCT06959277?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-06-17. Estimated completion is 2027-12-31.

What conditions does trial NCT06959277 study?

This clinical trial studies the following conditions: Peripheral Neuropathy Due to Chemotherapy, Peripheral Neuropathies, Peripheral Neuropathy With Type 2 Diabetes, Balance Control in Elderly, Gait Disorders.

What interventions are being tested in trial NCT06959277?

The interventions under investigation include: Walkasins (DEVICE), Fall Prevention Training (OTHER).

Who is sponsoring clinical trial NCT06959277?

This trial is sponsored by RxFunction, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06959277 being conducted?

This trial has 6 study locations across Arizona, Massachusetts, Minnesota, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Peripheral Neuropathy Due to Chemotherapy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Peripheral Neuropathy Due to Chemotherapy

All registered trials for this condition

Peripheral Neuropathies

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.